IL-15 Stimulates the Expansion of AIDS Virus-Specific CTL

Journal of Immunology

Volumn 157, Issue 8, 1996, Pages 3681-3687

  Kanai, Takanori ^a   Thomas, Elaine K ^b   Yasutomi, Yasuhiro ^a   Letvin, Norman L ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 15; INTERLEUKIN 2; ONCOPROTEIN; TRANSMEMBRANE PROTEIN, SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS ENVELOPE PROTEIN; VIRUS FUSION PROTEIN;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CYTOTOXIC T LYMPHOCYTE; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; MACACA; SIMIAN IMMUNODEFICIENCY VIRUS;

AMINO ACID SEQUENCE; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; GENE PRODUCTS, ENV; HIV INFECTIONS; HIV-1; HUMANS; INTERLEUKIN-15; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MACACA MULATTA; RETROVIRIDAE PROTEINS, ONCOGENIC; SIMIAN IMMUNODEFICIENCY VIRUS; T-LYMPHOCYTES, CYTOTOXIC; VIRAL FUSION PROTEINS;

EID: 0030587823     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Sitkovsky, M. V., and P. A. Henkart. 1993. Cytotoxic Cells: Recognition, Effector Function, Generation, and Method. Birkhauser, Boston.
2. Carini, C., and M. Essex. 1994. Interleukin 2-independent interleukin 7 activity enhances cytotoxic immune response of HIV-1 infected individuals. AIDS Res. Hum. Retro. 10:121.
3. Ferrari, G., K. King, K. Rathbun, C. A. Place, M. V., Packard, J. A. Bartlett, D. P. Bolognesi, and K. J. Weinhold. 1995. IL-7 enhancement of antigen-driven activation/expansion of HIV-1-specific cytotoxic T lymphocyte precursors (CTLp). Clin. Exp. Immunol. 101:239.
4. Schwartz, R. H. 1992. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 71: 1065.
5. Grabstein, K. H., J. Eisenman, K. Shanebeck, C. Rauch, S. Srinivasan, V. Fung, C. Beers, J. Richardson, M. A. Schoenborn, L. Johnson, M. R. Alderson, J. D. Watson, D. M. Anderson, and J. G. Giri. 1995. Cloning of a T cell growth factor that interacts with the β chain of the interleukin-2 receptor. Science 264:965.
6. Carson, W. E., J. G. Giri, M. J. Lindemann, M. L. Linett, M. Ahdieh, R. Paxton, D. Anderson, J. Eisenman, K. Grabstein, and M. A. Caligiuri. 1994. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J. Exp. Med. 180:1895.
7. Carson, W. E., M. E. Ross, R. A. Baiocchi, J. J. Marien, N. Boiani, K. Grabstein, and M. A. Caligiuri. 1995. Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-γ by natural killer cells. J. Clin. Invest. 96:2378.
8. Giri, J. G., M. Ahdieh, J. Eisenman, K. Shanebeck, K. Grabstein, S. Kumaki, A. Namen, L. S. Park, D. Cosman, and D. Anderson. 1994. Utilization of the β and γ chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J. 13:2822.
9. Anderson, D. M., S. Kumaki, M. Ahdieh, J. Bertles, M. Tometsko, A. Loomis, J. Giri, N. G. Copeland, D. J. Gilbert, N. A. Jenkins, V. Valentine, D. N. Shapiro, S. W. Morris, L. S. Park, and D. Cosman. 1995. Functional characterization of the human interleukin-15 receptor alpha chain and close linkage of IL15RA and IL2RA genes. J. Biol. Chem. 270:29862.
10. Giri, J. G., S. Kumaki, M. Ahdieh, D. J. Friend, A. Loomis, K. Shanebeck, R. DuBose, D. Cosman, L. S. Park, and D. M. Anderson. 1995. Identification and cloning of a novel IL-15 binding protein that is structurally related to the α chain of the IL-2 receptor. EMBO J. 14:3654.
11. Cosman, D., D. M. Anderson, K. H. Grabstein, K. Shanebeck, M. Kumaki, M. Ahdieh, and J. G. Giri. 1994. IL-15, a novel T cell growth factor, that shares components of the receptor for IL-2. In Challenges of Modern Medicine, Vol. 8: Cytokines: Basic Principles and Practical Applications. S. Romagnani, G. Del Prete, and A. K. Abbas, eds. Ames-Serono Symposia Publications, Rome, pp. 77-86.
12. Desrosiers, R. C. 1990. The simian immunodeficiency viruses. Annu. Rev. Immunol. 8:557.
13. mac virus that expresses the HIV-1 envelope glycoproteins. J. Acquired Immune Defic. Syndr. 5:639.
14. Watkins, D. I., M. Kannagi, M. E. Stone, and N. L. Letvin. 1988. Major histocompatibility complex class I molecules of nonhuman primates. Eur. J. Immunol. 18:1425.
15. mac-infected rhesus monkeys. J. Immunol. 147:320.
16. Voss, G., and N. L. Letvin. 1996. Definition of HIV-1 gp120 and gp41 CTL epitopes and their restricting MHC class I alleles in simian-human immunodeficiency virus-infected rhesus monkeys. J. Virol. In press.
17. Johnson, R. P., A. Trocha, L. Yang, G. P. Mazzara, D. L. Panicali, T. M. Buchanan, and B. D. Walker. 1991. HIV-1 gag-specific cytotoxic T lymphocytes recognize multiple highly conserved epitopes. J. Immunol. 147:1512.
18. + T cells in the central region of the HIV-1 Nef protein J. Immunol. 146:1560.
19. Gotch, F. M., D. F. Nixon, N. Alp, A. J. McMichael, and L. K. Borysiewicz. 1990. High frequency of memory and effector gag specific cytotoxic T lymphocytes in HIV seropositive individuals. Int. Immunol. 2:707.
20. + cytotoxic T lymphocytes. J. Exp. Med. 176:1739.
21. von Herrath, M. G., M. Yokoyama, J. Dockter, M. A. Oldstone, and J. L. Whitton. 1996. CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge. J. Virol. 70:1072.
22. Avery, A. C., J. S. Markowitz, M. J. Grusby, L. H. Glimcher, and H. Cantor. 1994. Activation of T cells by superantigen in class II-negative mice. J. Immunol. 153:4853.
23. Kovacs, J. A., M. Baseler, R. J. Dewar, S. Vogel, R. T. Davey, J. Falloon, M. A. Polis, R. E. Walker, R. Stevens, N. P. Salzman, J. A. Metcalf, H. Masur, and H. C. Lane. 1994. Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection: a preliminary study. N. Engl. J. Med. 332:567.